Kevin S. Katen

Combined effects of lavendamycin analogs and AZT on HIV-reverse transcriptase : an honors thesis (HONRS 499)

Kevin S. Katen, 2003 .

Generating diversity in human glucocorticoid signaling through a racially diverse polymorphism in the beta isoform of the glucocorticoid receptor

Kevin S. Katen, J. Cidlowski, S. Garantziotis, 2017, Laboratory Investigation.

Healthy glucocorticoid receptor N363S carriers dysregulate gene expression associated with metabolic syndrome.

Kevin S. Katen, J. Cidlowski, S. Garantziotis, 2016, American journal of physiology. Endocrinology and metabolism.

Endocrine and Metabolic Dysfunction during Aging and Senescence Healthy glucocorticoid receptor N 363 S carriers dysregulate gene expression associated with metabolic syndrome

Kevin S. Katen, P. Higgins, S. Cole, 2016 .

Glucocorticoid Receptor Mutations and Hypersensitivity to Endogenous and Exogenous Glucocorticoids

Kevin S. Katen, D. Heitjan, H. Raff, 2018, The Journal of clinical endocrinology and metabolism.

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.

Kevin S. Katen, Maureen F. Maughan, D. Bernstein, 2009, Vaccine.

Novel lavendamycin analogues as potent HIV-reverse transcriptase inhibitors: synthesis and evaluation of anti-reverse transcriptase activity of amide and ester analogues of lavendamycin.

Kevin S. Katen, Aiqin Wang, Daniel A. Briere, 2003, Journal of medicinal chemistry.

Combined Effects ofLavendamycin Analogs and AZT on HIV-Reverse Transcriptase

Kevin S. Katen, Wen Cai, N. Behforouz, 2003 .

Race-specific association of an IRGM risk allele with cytokine expression in human subjects

Kevin S. Katen, P. Rai, J. Madenspacher, 2023, Scientific reports.

Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers.

Kevin S. Katen, Maureen F. Maughan, D. Bernstein, 2009, Vaccine.